Home » FDA Releases Warning Letter on Novartis Violations
FDA Releases Warning Letter on Novartis Violations
The FDA released a warning letter it sent to Novartis AG last month, which said the drug maker’s generic-drug unit so far has failed to correct repeated manufacturing violations.
MarketWatch
MarketWatch
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May